FI962987A - Analyysi geenien transkription vertailuun - Google Patents

Analyysi geenien transkription vertailuun Download PDF

Info

Publication number
FI962987A
FI962987A FI962987A FI962987A FI962987A FI 962987 A FI962987 A FI 962987A FI 962987 A FI962987 A FI 962987A FI 962987 A FI962987 A FI 962987A FI 962987 A FI962987 A FI 962987A
Authority
FI
Finland
Prior art keywords
transcription
genes
comparison
analysis
Prior art date
Application number
FI962987A
Other languages
English (en)
Swedish (sv)
Other versions
FI962987A0 (fi
Inventor
Jeffrey J Seilhamer
Randal W Scott
Original Assignee
Incyte Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/187,530 external-priority patent/US5840484A/en
Application filed by Incyte Pharma Inc filed Critical Incyte Pharma Inc
Publication of FI962987A0 publication Critical patent/FI962987A0/fi
Publication of FI962987A publication Critical patent/FI962987A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/10—Sequence alignment; Homology search
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G16B30/20—Sequence assembly
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/10—Design of libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G16B35/20—Screening of libraries
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B35/00—ICT specially adapted for in silico combinatorial libraries of nucleic acids, proteins or peptides
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16C—COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
    • G16C20/00—Chemoinformatics, i.e. ICT specially adapted for the handling of physicochemical or structural data of chemical particles, elements, compounds or mixtures
    • G16C20/60—In silico combinatorial chemistry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medical Informatics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Molecular Biology (AREA)
  • Library & Information Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
FI962987A 1994-01-27 1996-07-26 Analyysi geenien transkription vertailuun FI962987A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/187,530 US5840484A (en) 1992-07-17 1994-01-27 Comparative gene transcript analysis
US08/282,955 US6114114A (en) 1992-07-17 1994-07-29 Comparative gene transcript analysis
PCT/US1995/001160 WO1995020681A1 (en) 1994-01-27 1995-01-27 Comparative gene transcript analysis

Publications (2)

Publication Number Publication Date
FI962987A0 FI962987A0 (fi) 1996-07-26
FI962987A true FI962987A (fi) 1996-09-26

Family

ID=26883115

Family Applications (1)

Application Number Title Priority Date Filing Date
FI962987A FI962987A (fi) 1994-01-27 1996-07-26 Analyysi geenien transkription vertailuun

Country Status (17)

Country Link
US (1) US6114114A (fi)
EP (1) EP0748390A4 (fi)
JP (1) JPH09503921A (fi)
CN (1) CN1145098A (fi)
AP (1) AP9600833A0 (fi)
AU (1) AU688465B2 (fi)
BG (1) BG100751A (fi)
BR (1) BR9506657A (fi)
CA (1) CA2182217A1 (fi)
CZ (1) CZ218996A3 (fi)
EE (1) EE9600097A (fi)
FI (1) FI962987A (fi)
LV (1) LV11696B (fi)
NO (1) NO963151L (fi)
OA (1) OA10723A (fi)
PL (1) PL315687A1 (fi)
WO (1) WO1995020681A1 (fi)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040138A (en) * 1995-09-15 2000-03-21 Affymetrix, Inc. Expression monitoring by hybridization to high density oligonucleotide arrays
US6600996B2 (en) 1994-10-21 2003-07-29 Affymetrix, Inc. Computer-aided techniques for analyzing biological sequences
US6974666B1 (en) 1994-10-21 2005-12-13 Appymetric, Inc. Methods of enzymatic discrimination enhancement and surface-bound double-stranded DNA
US5866330A (en) 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5695937A (en) * 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5972693A (en) * 1995-10-24 1999-10-26 Curagen Corporation Apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US5871697A (en) 1995-10-24 1999-02-16 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US6418382B2 (en) 1995-10-24 2002-07-09 Curagen Corporation Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing
US20010018514A1 (en) 1998-07-31 2001-08-30 Mcgall Glenn H. Nucleic acid labeling compounds
US7291463B2 (en) 1996-01-23 2007-11-06 Affymetrix, Inc. Nucleic acid labeling compounds
US6965020B2 (en) 1996-01-23 2005-11-15 Affymetrix, Inc. Nucleic acid labeling compounds
US7423143B2 (en) 1996-01-23 2008-09-09 Affymetrix. Inc. Nucleic acid labeling compounds
US6864059B2 (en) 1996-01-23 2005-03-08 Affymetrix, Inc. Biotin containing C-glycoside nucleic acid labeling compounds
US7282327B2 (en) 1996-01-23 2007-10-16 Affymetrix, Inc. Nucleic acid labeling compounds
US6312892B1 (en) * 1996-07-19 2001-11-06 Cornell Research Foundation, Inc. High fidelity detection of nucleic acid differences by ligase detection reaction
US5939265A (en) * 1996-11-05 1999-08-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
AU4753397A (en) * 1996-10-03 1998-04-24 Incyte Pharmaceuticals, Inc. Methods for generating and analyzing transcript markers
US5919638A (en) * 1996-10-08 1999-07-06 Abbott Laboratories Reagents and methods useful for detecting prostate tumors
EP0939824B1 (en) * 1996-10-31 2007-06-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
US20050202499A1 (en) 1996-10-31 2005-09-15 Billing-Medel Patricia A. Reagents and methods useful for detecting diseases of the breast
US5981190A (en) * 1997-01-08 1999-11-09 Ontogeny, Inc. Analysis of gene expression, methods and reagents therefor
US6461814B1 (en) * 1997-01-15 2002-10-08 Dominic G. Spinella Method of identifying gene transcription patterns
US5968784A (en) * 1997-01-15 1999-10-19 Chugai Pharmaceutical Co., Ltd. Method for analyzing quantitative expression of genes
CA2279551A1 (en) * 1997-01-31 1998-08-06 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
JP2001522238A (ja) 1997-03-31 2001-11-13 アボツト・ラボラトリーズ 胃腸管の疾患の検出に有用な試薬および方法
US6867016B1 (en) 1997-03-31 2005-03-15 Abbott Laboratories Reagents and methods useful for detecting diseases of the gastrointestinal tract
US6368792B1 (en) 1997-03-31 2002-04-09 Abbott Laboratories Reagents and methods useful for detecting diseases of the gastrointestinal tract
WO1998044160A1 (en) * 1997-03-31 1998-10-08 Abbott Laboratories Reagents and methods useful for detecting diseases of the gastrointestinal tract
US5966711A (en) * 1997-04-15 1999-10-12 Alpha Gene, Inc. Autonomous intelligent agents for the annotation of genomic databases
NO972006D0 (no) * 1997-04-30 1997-04-30 Forskningsparken I Aas As Ny metode for diagnose av sykdommer
US6130043A (en) 1997-05-02 2000-10-10 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
US6890749B2 (en) 1997-05-15 2005-05-10 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
WO1998051824A1 (en) * 1997-05-15 1998-11-19 Abbott Laboratories Reagents and methods useful for detecting disease of the urinary tract
CA2292759A1 (en) 1997-06-05 1998-12-10 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
WO1998056951A1 (en) * 1997-06-11 1998-12-17 Abbott Laboratories Reagents and methods useful for detecting diseases of the lung
EP1003779A1 (en) * 1997-07-07 2000-05-31 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999002714A1 (en) * 1997-07-07 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
WO1999002734A1 (en) * 1997-07-08 1999-01-21 Abbott Laboratories Reagents and methods useful for detecting diseases of the urinary tract
US20020064792A1 (en) * 1997-11-13 2002-05-30 Lincoln Stephen E. Database for storage and analysis of full-length sequences
WO1999025850A1 (en) * 1997-11-17 1999-05-27 Abbott Laboratories Reagents and methods useful for detecting diseases of the breast
EP1042504A2 (en) * 1997-12-29 2000-10-11 Genena Ltd. A method for identifying and characterizing cells and tissues
US6121023A (en) 1998-01-22 2000-09-19 Akzo Nobel N.V. Isothermal transcription based assay for the detection and quantification of the chemokine rantes
CA2323058C (en) 1998-03-31 2011-03-29 Genzyme Corporation Methods for the diagnosis and treatment of lung cancer by detection of proto-oncogene overexpression
US6484105B2 (en) * 1998-04-02 2002-11-19 Maxyag, Inc. Method for obtaining a plant with a genetic lesion in a gene sequence
US6403778B1 (en) 1998-05-04 2002-06-11 Incyte Genomics, Inc. Toxicological response markers
AU6022299A (en) * 1998-08-28 2000-03-21 Incyte Pharmaceuticals, Inc. Toxicological response markers
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
US6453241B1 (en) 1998-12-23 2002-09-17 Rosetta Inpharmatics, Inc. Method and system for analyzing biological response signal data
AU2596800A (en) * 1998-12-31 2000-07-31 Iconix Pharmaceuticals, Inc. Method for generating a pathway reporter system
EP1268758A2 (en) * 1999-06-01 2003-01-02 Incyte Genomics, Inc. Molecules for diagnostics and therapeutics
US6960439B2 (en) 1999-06-28 2005-11-01 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
WO2001011032A1 (en) * 1999-08-05 2001-02-15 Incyte Genomics, Inc. Secretory molecules
US7244559B2 (en) * 1999-09-16 2007-07-17 454 Life Sciences Corporation Method of sequencing a nucleic acid
US7211390B2 (en) 1999-09-16 2007-05-01 454 Life Sciences Corporation Method of sequencing a nucleic acid
AU7709300A (en) * 1999-09-24 2001-04-24 Linden Technologies, Inc. Drug discovery using gene expression profiling
WO2001077668A2 (en) * 2000-04-10 2001-10-18 The Scripps Research Institute Proteomic analysis using active-site directed probes
GB0008908D0 (en) * 2000-04-11 2000-05-31 Hewlett Packard Co Shopping assistance service
US7363165B2 (en) * 2000-05-04 2008-04-22 The Board Of Trustees Of The Leland Stanford Junior University Significance analysis of microarrays
JP2004500846A (ja) * 2000-05-11 2004-01-15 アカデミス　ジーケンホイス　ベイ　デ　ユニフェルジテイト　ファン　アムステルダム Ｍｙｃ標的
WO2001099043A1 (en) * 2000-06-19 2001-12-27 Correlogic Systems, Inc. Heuristic method of classification
WO2002008453A2 (en) * 2000-07-21 2002-01-31 Phase-1 Molecular Toxicology Canine toxicity genes
US7110885B2 (en) 2001-03-08 2006-09-19 Dnaprint Genomics, Inc. Efficient methods and apparatus for high-throughput processing of gene sequence data
CA2440615A1 (en) 2001-03-12 2002-09-19 Affymetrix, Inc. Nucleic acid labeling compounds
CA2377213A1 (en) * 2001-03-20 2002-09-20 Ortho-Clinical Diagnostics, Inc. Method for providing clinical diagnostic services
US6996477B2 (en) 2001-04-19 2006-02-07 Dana Farber Cancer Institute, Inc. Computational subtraction method
AUPR480901A0 (en) * 2001-05-04 2001-05-31 Genomics Research Partners Pty Ltd Diagnostic method for assessing a condition of a performance animal
EP1417475A4 (en) * 2001-07-06 2006-06-28 454 Corp METHOD FOR ISOLATING INDEPENDENT, PARALLEL CHEMICAL MICRORE ACTIONS USING A POROUS FILTER
US20030148314A1 (en) * 2001-08-01 2003-08-07 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of colon cancer
US20030054396A1 (en) * 2001-09-07 2003-03-20 Weiner Michael P. Enzymatic light amplification
US20050124022A1 (en) * 2001-10-30 2005-06-09 Maithreyan Srinivasan Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6956114B2 (en) 2001-10-30 2005-10-18 '454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
US6902921B2 (en) * 2001-10-30 2005-06-07 454 Corporation Sulfurylase-luciferase fusion proteins and thermostable sulfurylase
CA2466502A1 (en) 2001-11-09 2003-05-15 Source Precision Medicine, Inc. Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
US7776524B2 (en) 2002-02-15 2010-08-17 Genzyme Corporation Methods for analysis of molecular events
US20050136457A1 (en) * 2002-05-22 2005-06-23 Fujitsu Limited Method for analyzing genome
US20050158742A1 (en) * 2002-05-22 2005-07-21 Fujitsu Limited Method for analyzing genome
AU2003268031A1 (en) * 2002-07-29 2004-02-16 Correlogic Systems, Inc. Quality assurance/quality control for electrospray ionization processes
EP1431399A1 (en) * 2002-12-20 2004-06-23 Clinigenetics Methods and composition for identifying therapeutic agents of atherosclerotic plaque lesions
US7575865B2 (en) * 2003-01-29 2009-08-18 454 Life Sciences Corporation Methods of amplifying and sequencing nucleic acids
EP1590477B1 (en) * 2003-01-29 2009-07-29 454 Corporation Methods of amplifying and sequencing nucleic acids
AU2004261222A1 (en) * 2003-08-01 2005-02-10 Correlogic Systems, Inc. Multiple high-resolution serum proteomic features for ovarian cancer detection
GB0412301D0 (en) 2004-06-02 2004-07-07 Diagenic As Product and method
WO2006026654A2 (en) 2004-08-27 2006-03-09 Exact Sciences Corporation Method for detecting a recombinant event
US9109256B2 (en) 2004-10-27 2015-08-18 Esoterix Genetic Laboratories, Llc Method for monitoring disease progression or recurrence
WO2007053170A2 (en) * 2005-02-09 2007-05-10 Correlogic Systems, Inc. Identification of bacteria and spores
US9777314B2 (en) 2005-04-21 2017-10-03 Esoterix Genetic Laboratories, Llc Analysis of heterogeneous nucleic acid samples
US20080312514A1 (en) * 2005-05-12 2008-12-18 Mansfield Brian C Serum Patterns Predictive of Breast Cancer
WO2007007519A1 (ja) * 2005-07-07 2007-01-18 Sony Corporation エバネッセント光を利用する物質情報取得方法と物質情報測定装置、並びに塩基配列決定方法と装置
US7608395B2 (en) 2005-09-15 2009-10-27 Baylor Research Institute Systemic lupus erythematosus diagnostic assay
US8158360B2 (en) 2005-12-08 2012-04-17 Novartis Ag Effects of inhibitors of FGFR3 on gene transcription
MX360595B (es) 2006-02-08 2018-11-09 Genzyme Corp Terapia génica para la enfermedad de niemann-pick de tipo a.
US20080250016A1 (en) * 2007-04-04 2008-10-09 Michael Steven Farrar Optimized smith-waterman search
MY150234A (en) 2007-06-29 2013-12-31 Ahn Gook Pharmaceutical Company Ltd Predictive markers for ovarian cancer
CN101930502B (zh) * 2010-09-03 2011-12-21 深圳华大基因科技有限公司 表型基因的检测及生物信息分析的方法及系统
US11021703B2 (en) 2012-02-16 2021-06-01 Cornell University Methods and kit for characterizing the modified base status of a transcriptome

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371671A (en) * 1990-03-13 1994-12-06 The Regents Of The University Of California DNA sequence autoradiogram digitizer and methodology implemented in the same
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5364759B2 (en) * 1991-01-31 1999-07-20 Baylor College Medicine Dna typing with short tandem repeat polymorphisms and identification of polymorphic short tandem repeats
AU669489B2 (en) * 1991-09-18 1996-06-13 Affymax Technologies N.V. Method of synthesizing diverse collections of oligomers
US5270170A (en) * 1991-10-16 1993-12-14 Affymax Technologies N.V. Peptide library and screening method
US5541061A (en) * 1992-04-29 1996-07-30 Affymax Technologies N.V. Methods for screening factorial chemical libraries

Also Published As

Publication number Publication date
EE9600097A (et) 1996-12-16
JPH09503921A (ja) 1997-04-22
BG100751A (en) 1997-07-31
LV11696B (en) 1997-08-20
AU688465B2 (en) 1998-03-12
US6114114A (en) 2000-09-05
NO963151D0 (no) 1996-07-26
AP9600833A0 (en) 1996-07-31
CA2182217A1 (en) 1995-08-03
EP0748390A4 (en) 1998-04-01
CZ218996A3 (en) 1997-05-14
NO963151L (no) 1996-09-27
OA10723A (en) 2002-12-04
PL315687A1 (en) 1996-11-25
WO1995020681A1 (en) 1995-08-03
FI962987A0 (fi) 1996-07-26
BR9506657A (pt) 1997-09-16
EP0748390A1 (en) 1996-12-18
AU1694695A (en) 1995-08-15
CN1145098A (zh) 1997-03-12

Similar Documents

Publication Publication Date Title
FI962987A (fi) Analyysi geenien transkription vertailuun
FI972429A (fi) Menetelmä ja laite DNA:n sekvensoimiseksi ja DNA:n identifioimiseksi
FI950035A0 (fi) Parannettu menetelmä karvojen poistamiseksi
BR9510279A (pt) Formas de processamento de dados foto-apagáveis
FI950576A0 (fi) Foerfarande och anordning foer rengoering av sugluft i en gasturbin
FI980853A0 (fi) Uusi DNA ja menetelmä proteiinin valmistamiseksi käyttäen DNA:ta
FI955777A (fi) Menetelmä ja tuotteisto hiusten käsittelyn suorittamiseksi
FI964783A (fi) Menetelmä syövän hoitamiseksi p53-proteiinia säätelemällä
FI950472A0 (fi) Foerfarande foer framstaellning av en konstgjord produkt och skinnprodukt
FI950102A (fi) Järjestelmä kalojen käyttäytymisen analysoimiseksi
NO960391L (no) Fremgangsmåte for utvinning av fiskemel
FI962655A0 (fi) Foerfarande och anordning foer behandling av tjock massa
FI973011A0 (fi) Foerfarande och anordning foer behandling av massa
FI962865A0 (fi) Foerfarande och anordningar foer behandling av massa
FI962636A0 (fi) Foerfarande och anordningar foer silning av massa
SE9502546D0 (sv) Sätt vid förfarande för analys
FI965044A0 (fi) Puheentunnistusmenetelmä
FI952557A0 (fi) Foerfarande foer skapande av talfoerbindelse mellan naet och inteeligent naett jaenst
FI962508A0 (fi) Foerfarande foer rening av avloppsvatten genom anvaendning av jord
FI945156A0 (fi) System foer foerbaettrande av inboerdes vaexelverkan mellan affaeren och kunden
FI951523A0 (fi) Foerfarande foer utfoerande av neuralalkyl genom att anvaenda sjaelvorganiserande karta och foerfarandets tilllaempningar
FI962889A0 (fi) Rengoering av roer och haoligheter genom elektrolysmetod
SE9503208D0 (sv) New DNA molecules III
SE9504148D0 (sv) Lösningsmedel och förfarande
FI974500A0 (fi) Foerfarande foer rening av anvaenda saltsyrebaserade etsnings- och betningssyreavfallsloesningar genom jonbyte och indunstning foer aotervinning

Legal Events

Date Code Title Description
FD Application lapsed